Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 18/20 | 0.98 |
| ▸ | MTOR | P42345 | 1/20 | 0.98 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.98 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gpi-1046 SCHEMBL7187 | 0.99 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL4766380 | 0.99 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL7324245 | 0.98 | FKBP1A (0.98) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL2542494 | 0.97 | FKBP1A (0.96) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL182073 | 0.96 | FKBP1A (0.95) | FKBP1AMTORFKBP4FKBP5 | |
| SCHEMBL5965941 | 0.96 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 | |
| SCHEMBL7246114 | 0.94 | FKBP1A (0.90) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL2537059 | 0.93 | FKBP1A (0.89) | FKBP1AMTORFKBP4FKBP5 | |
| Gpi-1046 SCHEMBL19386253 | 0.93 | FKBP1A (0.87) | FKBP1AMTORFKBP4FKBP5 | |
| SCHEMBL7767569 | 0.91 | FKBP1A (1.00) | FKBP1AMTORFKBP4FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2353686-B1 | METHOD FOR PURIFYING FK506 BY EXTRACTION WITH SILVER ION SOLUTION | GENOTECH CORP (KR) | 2016-11-09 | — | — | EP | disclosed |
| US-8193345-B2 | Purification method of lactone compounds containing unsaturated alkyl group by extraction with silver ion solution | GENOTECH CORP. (KR) | 2012-06-05 | — | — | US | disclosed |
| EP-2353686-A1 | METHOD FOR PURIFYING LACTONE COMPOUND HAVING UNSATURATED ALKYL GROUP BY EXTRACTION WITH SILVER ION SOLUTION | Genotech Co., Ltd (KR) | 2011-08-10 | — | — | EP | disclosed |
| US-20110172413-A1 | PURIFICATION METHOD OF LACTONE COMPOUNDS CONTAINING UNSATURATED ALKYL GROUP BY EXTRACTION WITH SILVER ION SOLUTION | GENOTECH CO., LTD (KR) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172413-A1 | PURIFICATION METHOD OF LACTONE COMPOUNDS CONTAINING UNSATURATED ALKYL GROUP BY EXTRACTION WITH SILVER ION SOLUTION | FKBP2, FKBP8, FKBP5 | FKBP1A 8/4885MTOR 154/4885FKBP4 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.